European Journal of Obstetrics & Gynecology and Reproductive Biology
Volume 149, Issue 2 , Pages 127-130 , April 2010

Fetal programming of atherosclerosis: Possible role of the mitochondria

  • Line Leduc

      Affiliations

    • Department of Obstetrics and Gynaecology, Université de Montréal, Research Centre, CHU Sainte-Justine, Montreal, Quebec, Canada
    • Corresponding Author InformationCorresponding author at: Department of Obstetrics and Gynaecology, Maternal-Foetal Medicine Division, CHU Sainte-Justine, 3175 Côte Sainte-Catherine, Montreal, QC, Canada H3T 1C5. Tel.: +1 514 345 4706; fax: +1 514 345 4648.
    • ,
  • Emile Levy

      Affiliations

    • Department of Nutrition, Université de Montréal, Research Centre, CHU Sainte-Justine, Montreal, Quebec, Canada
    • ,
  • Maurice Bouity-Voubou

      Affiliations

    • Department of Nutrition, Université de Montréal, Research Centre, CHU Sainte-Justine, Montreal, Quebec, Canada
    • ,
  • Edgard Delvin

      Affiliations

    • Department of Biochemistry, Université de Montréal, Research Centre, CHU Sainte-Justine, Montreal, Quebec, Canada

Received 25 May 2009 ,Revised 2 November 2009 ,Accepted 4 December 2009.

References 

  1. Miller J, Turan S, Baschat AA. Fetal growth restriction. Semin Perinatol. 2008;32(August (4)):274–280
  2. Petersen SG, Wong SF, Urs P, Gray PH, Gardener GJ. Early onset, severe fetal growth restriction with absent or reversed end-diastolic flow velocity waveform in the umbilical artery: perinatal and long-term outcomes. Aust N Z J Obstet Gynaecol. 2009;49(February (1)):45–51
  3. Barker DJ. The developmental origins of chronic adult disease. Acta Paediatr Suppl. 2004;93(December (446)):26–33
  4. Cianfarani S, Germani D, Branca F. Low birthweight and adult insulin resistance: the “catch-up growth” hypothesis. Arch Dis Child Fetal Neonatal Ed. 1999;81(July (1)):F71–F73
  5. Cleal JK, Poore KR, Boullin JP, et al. Mismatched pre- and postnatal nutrition leads to cardiovascular dysfunction and altered renal function in adulthood. Proc Natl Acad Sci USA. 2007;104(May (22)):9529–9533
  6. Drake AJ, Walker BR. The intergenerational effects of fetal programming: non-genomic mechanisms for the inheritance of low birth weight and cardiovascular risk. J Endocrinol. 2004;180(January (1)):1–16
  7. Halvorsen CP, Andolf E, Hu J, Pilo C, Winbladh B, Norman M. Discordant twin growth in utero and differences in blood pressure and endothelial function at 8 years of age. J Intern Med. 2006;259(February (2)):155–163
  8. Pladys P, Sennlaub F, Brault S, et al. Microvascular rarefaction and decreased angiogenesis in rats with fetal programming of hypertension associated with exposure to a low-protein diet in utero. Am J Physiol Regul Integr Comp Physiol. 2005;289(December (6)):R1580–R1588
  9. Pesonen E, Johnsson J, Berg A. Intimal thickness of the coronary arteries in low-birthweight infants. Acta Paediatr. 2006;95(October (10)):1234–1238
  10. Madamanchi NR, Runge MS. Mitochondrial dysfunction in atherosclerosis. Circ Res. 2007;100(March (4)):460–473
  11. Davidson SM, Duchen MR. Endothelial mitochondria: contributing to vascular function and disease. Circ Res. 2007;100(April (8)):1128–1141
  12. Berliner JA, Heinecke JW. The role of oxidized lipoproteins in atherogenesis. Free Radic Biol Med. 1996;20(5):707–727
  13. Ross R. Atherosclerosis—an inflammatory disease. N Engl J Med. 1999;340(January (2)):115–126
  14. Danesh J, Wheeler JG, Hirschfield GM, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med. 2004;350(April (14)):1387–1397
  15. Schleicher E, Friess U. Oxidative stress, AGE, and atherosclerosis. Kidney Int Suppl 2007(August (106)):S17–26.
  16. Tousoulis D, Antoniades C, Koumallos N, Stefanadis C. Pro-inflammatory cytokines in acute coronary syndromes: from bench to bedside. Cytokine Growth Factor Rev. 2006;17(August (4)):225–233
  17. Verma S, Anderson TJ. Fundamentals of endothelial function for the clinical cardiologist. Circulation. 2002;105(February (5)):546–549
  18. Ludmer PL, Selwyn AP, Shook TL, et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med. 1986;315(October (17)):1046–1051
  19. Celermajer DS, Sorensen KE, Bull C, Robinson J, Deanfield JE. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol. 1994;24(November (6)):1468–1474
  20. Sorensen KE, Celermajer DS, Georgakopoulos D, Hatcher G, Betteridge DJ, Deanfield JE. Impairment of endothelium-dependent dilation is an early event in children with familial hypercholesterolemia and is related to the lipoprotein(a) level. J Clin Invest. 1994;93(January (1)):50–55
  21. Juonala M, Viikari JS, Laitinen T, et al. Interrelations between brachial endothelial function and carotid intima-media thickness in young adults: the cardiovascular risk in young Finns study. Circulation. 2004;110(November (18)):2918–2923
  22. Jarvisalo MJ, Raitakari M, Toikka JO, et al. Endothelial dysfunction and increased arterial intima-media thickness in children with type 1 diabetes. Circulation. 2004;109(April (14)):1750–1755
  23. Luo ZC, Fraser WD, Julien P, et al. Tracing the origins of “fetal origins” of adult diseases: programming by oxidative stress?. Med Hypotheses. 2006;66(1):38–44
  24. Crispi F, Dominguez C, Llurba E, Martin-Gallan P, Cabero L, Gratacos E. Placental angiogenic growth factors and uterine artery Doppler findings for characterization of different subsets in preeclampsia and in isolated intrauterine growth restriction. Am J Obstet Gynecol. 2006;195(July (1)):201–207
  25. Street ME, Seghini P, Fieni S, et al. Changes in interleukin-6 and IGF system and their relationships in placenta and cord blood in newborns with fetal growth restriction compared with controls. Eur J Endocrinol. 2006;155(October (4)):567–574
  26. Bartha JL, Romero-Carmona R, Comino-Delgado R. Inflammatory cytokines in intrauterine growth retardation. Acta Obstet Gynecol Scand. 2003;82(December (12)):1099–1102
  27. Holcberg G, Huleihel M, Sapir O, et al. Increased production of tumor necrosis factor-alpha TNF-alpha by IUGR human placentae. Eur J Obstet Gynecol Reprod Biol. 2001;94(January (1)):69–72
  28. Johnson MR, Anim-Nyame N, Johnson P, Sooranna SR, Steer PJ. Does endothelial cell activation occur with intrauterine growth restriction?. BJOG. 2002;109(July (7)):836–839
  29. Trudinger B, Wang J, Athayde N, Beutler L, Wang X. Association of umbilical placental vascular disease with fetal acute inflammatory cytokine responses. J Soc Gynecol Investig. 2002;9(May–June (3)):152–157
  30. Wang X, Athayde N, Trudinger B. A proinflammatory cytokine response is present in the fetal placental vasculature in placental insufficiency. Am J Obstet Gynecol. 2003;189(November (5)):1445–1451
  31. Hracsko Z, Orvos H, Novak Z, Pal A, Varga IS. Evaluation of oxidative stress markers in neonates with intra-uterine growth retardation. Redox Rep. 2008;13(1):11–16
  32. Casasco A, Calligaro A, Casasco M, et al. Immunohistochemical localization of lipoperoxidation products in normal human placenta. Placenta. 1997;18(May (4)):249–253
  33. Bayhan G, Kocyigit Y, Atamer A, Atamer Y, Akkus Z. Potential atherogenic roles of lipids, lipoprotein(a) and lipid peroxidation in preeclampsia. Gynecol Endocrinol. 2005;21(July (1)):1–6
  34. Atamer Y, Kocyigit Y, Yokus B, Atamer A, Erden AC. Lipid peroxidation, antioxidant defense, status of trace metals and leptin levels in preeclampsia. Eur J Obstet Gynecol Reprod Biol. 2005;119(March (1)):60–66
  35. Karowicz-Bilinska A, Kedziora-Kornatowska K, Bartosz G. Indices of oxidative stress in pregnancy with fetal growth restriction. Free Radic Res. 2007;41(August (8)):870–873
  36. Karowicz-Bilinska A, Kowalska-Koprek U, Suzin J, Sieroszewski P. Analysis of 8-isoprostane concentration as a marker of oxidative stress in pregnant women diagnosed with IUGR. Ginekol Pol. 2003;74(October (10)):1137–1142
  37. Biri A, Bozkurt N, Turp A, Kavutcu M, Himmetoglu O, Durak I. Role of oxidative stress in intrauterine growth restriction. Gynecol Obstet Invest. 2007;64(4):187–192
  38. Kanagalingam MG, Nelson SM, Freeman DJ, et al. Vascular dysfunction and alteration of novel and classic cardiovascular risk factors in mothers of growth restricted offspring. Atherosclerosis. 2009;205(July (1)):244–250
  39. Cheung YF, Wong KY, Lam BC, Tsoi NS. Relation of arterial stiffness with gestational age and birth weight. Arch Dis Child. 2004;89(March (3)):217–221
  40. Brodszki J, Lanne T, Marsal K, Ley D. Impaired vascular growth in late adolescence after intrauterine growth restriction. Circulation. 2005;111(May (20)):2623–2628
  41. Oren A, Vos LE, Uiterwaal CS, Gorissen WH, Grobbee DE, Bots ML. Birth weight and carotid intima-media thickness: new perspectives from the atherosclerosis risk in young adults (ARYA) study. Ann Epidemiol. 2004;14(January (1)):8–16
  42. Pesonen E, Kaprio J, Martimo P, Ruismaki A. Topography of intimal thickening in the left coronary artery of children compared with the topography of atherosclerosis. Coron Artery Dis. 1996;7(June (6)):459–465
  43. Kaprio J, Norio R, Pesonen E, Sarna S. Intimal thickening of the coronary arteries in infants in relation to family history of coronary artery disease. Circulation. 1993;87(June (6)):1960–1968
  44. Koklu E, Kurtoglu S, Akcakus M, et al. Increased aortic intima-media thickness is related to lipid profile in newborns with intrauterine growth restriction. Horm Res. 2006;65(6):269–275
  45. Leeson CP, Kattenhorn M, Morley R, Lucas A, Deanfield JE. Impact of low birth weight and cardiovascular risk factors on endothelial function in early adult life. Circulation. 2001;103(March (9)):1264–1268
  46. Martin H, Hu J, Gennser G, Norman M. Impaired endothelial function and increased carotid stiffness in 9-year-old children with low birthweight. Circulation. 2000;102(November (22)):2739–2744
  47. Bulteau AL, Szweda LI, Friguet B. Mitochondrial protein oxidation and degradation in response to oxidative stress and aging. Exp Gerontol. 2006;41(July (7)):653–657
  48. Knight-Lozano CA, Young CG, Burow DL, et al. Cigarette smoke exposure and hypercholesterolemia increase mitochondrial damage in cardiovascular tissues. Circulation. 2002;105(February (7)):849–854
  49. Lee JY, Jung GY, Heo HJ, et al. 4-Hydroxynonenal induces vascular smooth muscle cell apoptosis through mitochondrial generation of reactive oxygen species. Toxicol Lett. 2006;166(October (3)):212–221
  50. Llurba E, Gratacos E, Martin-Gallan P, Cabero L, Dominguez C. A comprehensive study of oxidative stress and antioxidant status in preeclampsia and normal pregnancy. Free Radic Biol Med. 2004;37(August (4)):557–570
  51. Watson AL, Skepper JN, Jauniaux E, Burton GJ. Susceptibility of human placental syncytiotrophoblastic mitochondria to oxygen-mediated damage in relation to gestational age. J Clin Endocrinol Metab. 1998;83(May (5)):1697–1705
  52. Walsh SW, Vaughan JE, Wang Y, Roberts LJ. Placental isoprostane is significantly increased in preeclampsia. FASEB J. 2000;14(July (10)):1289–1296
  53. Bernardi P, Krauskopf A, Basso E, et al. The mitochondrial permeability transition from in vitro artifact to disease target. FEBS J. 2006;273(May (10)):2077–2099
  54. Gordon LI, Burke MA, Singh AT, et al. Blockade of the erbB2 receptor induces cardiomyocyte death through mitochondrial and reactive oxygen species-dependent pathways. J Biol Chem. 2009;284(January (4)):2080–2087

PII: S0301-2115(09)00706-4

doi: 10.1016/j.ejogrb.2009.12.005

European Journal of Obstetrics & Gynecology and Reproductive Biology
Volume 149, Issue 2 , Pages 127-130 , April 2010

Article Tools